Holmes A R, McNab R, Jenkinson H F
Department of Oral Biology and Oral Pathology, University of Otago, Dunedin, New Zealand.
Infect Immun. 1996 Nov;64(11):4680-5. doi: 10.1128/iai.64.11.4680-4685.1996.
Candida albicans binds to several species of oral streptococci, in particular Streptococcus gordonii, through recognition of a streptococcal cell wall polysaccharide receptor (A. R. Holmes, P. K. Gopal, and H. F. Jenkinson, Infect. Immun. 63:1827-1834, 1995). We now show that isogenic cell surface protein mutants of S. gordonii DL1, unaltered in expression of cell wall polysaccharide, are reduced in ability to support adherence of C. albicans cells in a solid-phase assay. Inactivation of the S. gordonii cshA and cshB genes, encoding high-molecular-mass cell surface polypeptides, and inactivation of the sspA and sspB genes, encoding antigen I/II salivary adhesins, resulted in 40 and 79% reductions, respectively, in adherence of C. albicans cells. Inactivation of the S. gordonii scaA gene encoding a cell surface lipoprotein had no effect on C. albicans adherence. Polyclonal antiserum to streptococcal antigen I/II protein SpaP and antibodies specific to the amino-terminal nonrepetitive (NR) domain of CshA both inhibited adherence of C. albicans to S. gordonii cells. Conversely antibodies to the amino acid repeat block repetitive (R) domain of CshA, or to ScaA, did not inhibit C. albicans adherence. Immobilized recombinant polypeptide fragments of CshA comprising NR domain or R domain sequences both supported adherence of C. albicans cells. Expression of S. gordonii SspB protein on the surface of Enterococcus faecalis conferred on the enterococcal cells the ability to bind C. albicans, and this was ablated by antigen I/II antiserum. Collectively the results suggest that interaction of C. albicans with S. gordonii is mediated by a complement of adhesin-receptor interactions that involves two families of streptococcal multifunctional polypeptide adhesins, bacterial cell wall polysaccharide, and as yet unidentified yeast cell surface components.
白色念珠菌通过识别链球菌细胞壁多糖受体,与几种口腔链球菌,特别是戈登氏链球菌结合(A. R. 霍姆斯、P. K. 戈帕尔和H. F. 詹金森,《感染与免疫》63:1827 - 1834,1995年)。我们现在表明,戈登氏链球菌DL1的同基因细胞表面蛋白突变体,其细胞壁多糖表达未改变,但在固相试验中支持白色念珠菌细胞黏附的能力降低。编码高分子量细胞表面多肽的戈登氏链球菌cshA和cshB基因失活,以及编码抗原I/II唾液黏附素的sspA和sspB基因失活,分别导致白色念珠菌细胞黏附减少40%和79%。编码细胞表面脂蛋白的戈登氏链球菌scaA基因失活对白色念珠菌的黏附没有影响。针对链球菌抗原I/II蛋白SpaP的多克隆抗血清以及针对CshA氨基末端非重复(NR)结构域的特异性抗体,均抑制白色念珠菌对戈登氏链球菌细胞的黏附。相反,针对CshA氨基酸重复块重复(R)结构域或ScaA的抗体不抑制白色念珠菌的黏附。包含NR结构域或R结构域序列的固定化CshA重组多肽片段均支持白色念珠菌细胞的黏附。粪肠球菌表面表达戈登氏链球菌SspB蛋白赋予肠球菌细胞结合白色念珠菌的能力,并且这被抗原I/II抗血清消除。总体而言,结果表明白色念珠菌与戈登氏链球菌的相互作用是由黏附素 - 受体相互作用的组合介导的,这涉及链球菌多功能多肽黏附素的两个家族、细菌细胞壁多糖以及尚未确定的酵母细胞表面成分。